000 01196 a2200301 4500
005 20250518044808.0
264 0 _c20200612
008 202006s 0 0 eng d
022 _a1558-1977
024 7 _a10.1016/j.hoc.2019.03.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHunter, Bradley D
245 0 0 _aAllogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma.
_h[electronic resource]
260 _bHematology/oncology clinics of North America
_c08 2019
300 _a687-705 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xmethods
650 0 4 _aLymphoma, Non-Hodgkin
_xmortality
650 0 4 _aReceptors, Chimeric Antigen
_xtherapeutic use
650 0 4 _aStem Cell Transplantation
_xmethods
650 0 4 _aSurvival Analysis
650 0 4 _aTransplantation, Homologous
700 1 _aChen, Yi-Bin
700 1 _aJacobson, Caron A
773 0 _tHematology/oncology clinics of North America
_gvol. 33
_gno. 4
_gp. 687-705
856 4 0 _uhttps://doi.org/10.1016/j.hoc.2019.03.005
_zAvailable from publisher's website
999 _c29826006
_d29826006